Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Sales | 0 | 251 | 33,492 |
| Gross Profit | N/A | 251 | 33,492 |
| Operating Expenses | 89,810 | 67,533 | 64,163 |
| Operating Income | -89,810 | -67,282 | -30,671 |
| Other Income | 5,945 | 1,909 | 2,023 |
| Pre-tax Income | -83,865 | -65,373 | -28,648 |
| Income Tax | N/A | N/A | 72 |
| Net Income Continuous | -83,865 | -65,373 | -28,720 |
| Net Income | $-83,865 | $-65,373 | $-28,720 |
| EPS Basic Total Ops | -3.43 | -5.81 | -35.78 |
| EPS Basic Continuous Ops | -3.43 | -5.81 | -35.78 |
| EPS Diluted Total Ops | -3.43 | -5.81 | -35.78 |
| EPS Diluted Continuous Ops | -3.43 | -5.81 | -35.78 |
| EPS Diluted Before Non-Recurring Items | -3.43 | -5.49 | N/A |
| EBITDA(a) | $-87,213 | $-64,851 | $-28,405 |